Author, as appears in the article.: Sanchez-Gistau, V; Moreno, MJ; Gómez-Lus, S; Mainar, AS; Crespo-Facorro, B
Department: Medicina i Cirurgia
URV's Author/s: Sánchez Gistau, Vanessa
Thematic Areas: Biotecnología Ciência da computação Ciências biológicas i Ciências biológicas ii Ciências da religião e teologia Ciencias sociales Engenharias iv General medicine Interdisciplinar Matemática / probabilidade e estatística Medicina i Medicina ii Medicina iii Nutrição Psicología Psychiatry Psychiatry and mental health Química Saúde coletiva
licence for use: https://creativecommons.org/licenses/by/3.0/es/
Author's mail: vanessa.sanchezg@urv.cat
Record's date: 2024-01-13
Papper version: info:eu-repo/semantics/publishedVersion
Link to the original source: https://www.cambridge.org/core/journals/european-psychiatry/article/effect-of-aripiprazole-oncemonthly-400mg-aom400-on-hospitalisation-prevention-and-use-of-healthcare-resources-in-schizophrenia-patients-a-study-based-on-real-clinical-practice-on-schizophrenia-ambition-study/C441B4C65C5C84B1988B3AB704FF3334
Papper original source: European Psychiatry. 66 S494-S494
APA: Sanchez-Gistau, V; Moreno, MJ; Gómez-Lus, S; Mainar, AS; Crespo-Facorro, B (2023). Effect of aripiprazole once-monthly 400mg (AOM400) on hospitalisation prevention and use of healthcare resources in schizophrenia patients, a study based on real clinical practice on schizophrenia: AMBITION Study. European Psychiatry, 66(), S494-S494. DOI: 10.1192/j.eurpsy.2023.1052
Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
Article's DOI: 10.1192/j.eurpsy.2023.1052
Entity: Universitat Rovira i Virgili
Journal publication year: 2023
Publication Type: Journal Publications
Repositori URV